Management & founders
We are a comprehensive mix of experienced scientists and entrepreneurs. Our team brings together expertise in the medical and pharmaceutical industries as well as in the computer technology and business-to-business software sectors.
Kaisa Helminen, M.Sc, is the CEO of Aiforia Technologies Oy. Kaisa joined Aiforia in 2014 and has previously worked for international companies Sartorius, Thermo Fisher Scientific Inc. and a Finnish biotech company Finnzymes Oy. Kaisa has a strong background in life science sector where she has gained almost 20 years of experience in the global business. She has a wealth of experience in global sales, marketing and strategic product management in life science businesses.
Johan Lundin MD PhD is one of the co-founders of Aiforia as well as a Research Director at the Finnish Institute for Molecular Medicine (FIMM) at University of Helsinki and Professor of Medical Technology at Karolinska Institute. For more than 15 years he has developed technologies for diagnostic decision support with cloud-based and mobile solutions that allow the process to be performed remotely, by a human observer or using automated computerized analysis.
Mikael Lundin, MD, is one of the co-founders of Aiforia. He works as the Director of Concept Design at Aiforia Technologies Oy. Mikael is a pioneer in web-based virtual microscopy and has launched the first practical applications in 2002. He has published a series of central studies in virtual microscopy together with key opinion leaders in related fields. Mikael is fluent in a wide range of programming languages, and he has a special interest in database design and imaging.
Kari Pitkänen, M.Sc.Tech, is one of the co-founders of Aiforia. Kari is an experienced life-science entrepreneur having worked in the industry for over 30 years. He was one of the founders and Director of Marketing at Finnzymes Oy for 25 years, until its acquisition by Thermo Fisher Scientific in 2010.
Tuomas Ropponen, M.Sc.Tech, is the Chief Technology Officer at Aiforia Technologies Oy. Tuomas has extensive experience in developing deep learning AI and machine vision based systems and cloud infrastructures. He has previously worked for more than 20 years in international companies Outotec and Sartorius Biohit. Tuomas was one of the founders of Delta-Enterprise, known today as Roima Intelligence Inc.
Bill Maloy is the Sales Director for Aiforia’s North American operations. His focus is on broadening the company’s reach within the pharmaceutical and research industries across the region and building long term strategic partnerships with our customers. Bill has close to 20 years experience in sales and marketing within cloud and SaaS based startups with a focus on the life sciences sector, such as Cartagenia & GenomeQuest.
Joeri Blauw MSc, MBA is the Sales Director for Aiforia’s European operations.
Joeri has over 20 years of commercial experience in the pharmaceutical and medical devices industries. He has worked with AstraZeneca, Roche, Medtronic and Philips, in a variety of medical specialties, ranging from cardiology to pathology. In his last assignment he was responsible for European digital pathology sales in the life sciences businesses. Joeri’s focus is to expand Aiforia’s R&D business, as well as to introduce Aiforia’s platform into the clinical diagnostics space.
Thomas Westerling-Bui received his PhD in cancer biology, focusing on the cell cycle and transcription, from the University of Helsinki Medical School in Finland. He completed a post-doctoral EMBO fellowship at the Dana Farber Cancer Institute in Boston, researching the genomics of breast and prostate cancer. Tom joined Aiforia to advance the new potential of cancer biology, pathology, big data, and artificial intelligence.
Mikael Jääskeläinen is responsible for global sales and customer relations management for Aiforia. Mikael joined Aiforia in March 2014 having previously worked for international companies Sartorius, Thermo Fisher Scientific Inc. and Finnish biotech company Finnzymes Oy. Mikael has more than 25 years of experience in sales and marketing in the life science sector.
Pekka Mattila is the CEO of Desentum Oy. He holds board positions in several biotech and pharmaceutical companies. He is one of the founders of the Finnzymes Group and served as its CEO for 25 years until its acquisition by Thermo Fisher Scientific in 2010.
Monita Mo is a Hong Kong native with a professional career in Arthur Andersen NYC. She is a serial entrepreneur who has started three successful companies, including Ascend Capital Partners. She founded her own accounting firm in NYC in 1992 and her second company, Ascend Capital Partners in Beijing in 2002.
Johan Lundin MD PhD is one of the co-founders of Aiforia as well as a Research Director at the Finnish Institute for Molecular Medicine (FIMM) at University of Helsinki and Professor of Medical Technology at Karolinska Institute.
Timo Soininen is the CEO and co-founder of the rapidly growing gaming company, Small Giant Games. Timo is an experienced international digital growth executive and a startup activist with a strong concept building background.
Jukka Tapaninen is an experienced IT business executive currently working as the VP&Managing Director EMEA, APAC and Japan at Pegasystems Inc. Jukka has a strong background in the IT industry in companies like SAP and HP as well as experience in managing companies and business units globally.